Diagnostic Testing & Emerging Technologies   Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Diagnostic Testing & Emerging Technologies keeps you up-to-date on virtually everything you need to know about today's diagnostic testing market, including new diagnostic tests, emerging testing technologies, testing trends, test volume forecasts, new test approvals, new opportunities to increase your diagnostic testing revenue, and much more.
Join Now
Here's just a sample of the help you get from Diagnostic Testing & Emerging Technologies:
Newsletter
Industry Trends
  • Novel Tests Emerging For Overlooked Conditions
  • Researchers Develop First Multiplex Test for Tick-Borne Disease Detection
  • Fecal Profiling Could Personalize Diets with Irritable Bowel
  • Potential Upcoming Shifts for Diabetes-Related Diagnostic Testing
  • Expanded Carrier Screening IDs Rare Variants in Diverse Populations
  • FDA Set Record for Targeted Therapy Approvals
  • Genotype-Matched Diets Don’t Aid Weight Loss
  • Bilirubin as a Predictor of Neonatal Jaundice
  • Top 25 Lab Tests by Medicare Payment
  • Protein Patterns Investigated for Markers of Early Ovarian Cancer
  • Pap Test Fluids May Contain DNA Useful for Endometrial, Ovarian Cancer Diagnosis
  • Test Developed to Identify Alzheimer’s Risk
  • Artifcial Intelligence Merges Histology, Genomics to Predict Survival
  • FDA Approves First Objective Blood Test for Concussion Evaluation
  • Penicillin Skin Testing Can Delabel Misidentifed Allergic Patients
  • POC Susceptibility Testing No Aid for Antibiotic Prescribing with UTI
Precision Medicine
  • New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending
  • Dermatology Conference Highlights Gene Expression Tests for Skin Cancer
  • Study Shows Progress Towards a Blood-Based, Multi-Cancer Screen
  • Companion Diagnostics Driving New Model for Pharma-Dx Partnerships
  • C-reactive Protein May Inform Antidepressant Medication Selection
  • FDA Approves First-Ever, Pan-Cancer Drug in Milestone for Personalized Medicine
  • Genomic Markers May ID Risk of Chemo Side Effects
Testing Trends
  • Men Undergo Hereditary Cancer Testing Less Frequently Than Women
  • Home-Based Hospital Care Model Cuts Lab Utilization
  • Methods for Reanalysis of Exome Sequencing Emerging
  • Next-Gen Sequencing, AI Driving Investor Interest in Diagnostics Sector
  • Speed Record Set for Whole-Genome Sequencing
  • Molecular Testing Increasingly Adopted for Skin Cancer Diagnosis
  • Internet-Based Testing for STIs Increase Uptake
  • Teaching Hospitals Consistently Order More Lab Tests Per Patient
  • Chlamydia Testing Falls in Young Women, Following Change in Cervical Cancer Guidelines; Simultaneous Over-Testing of Males Seen
Test Technology & Operations
  • Innovation in Urine Collection Cuts Contamination, Retesting
  • Showing Test Prices May Not Change Ordering Behavior
  • IDWeek Tackles Improved Ordering Strategies
  • Unlocking Value in Laboratory Data
  • Payers Turning to Automated Pre-Approval Systems for Genetic Tests
  • Don’t Crash & Burn: Why Cutting Your Quality Department’s Budget is not a Good Idea
  • By the Numbers: Lab Injury and Exposure Data
  • Why Your Best Talent is Leaving and Four Ways to Win Them Back
  • Should You Be Paying Your Staff Overtime?
  • Decoding Quality Terminology
  • Push-Alerts of Lab Results Speeds Discharge from Emergency Dept
  • Getting A New Lab Space? Design It For Safety Now And Save Thousands Later
  • iSpecimen Creates Marketplace for Clinical Discards
Public Health Testing
  • HCV Screening Rates Very Low Among Exposed Infants
  • Mass. Settlement Could Speed HCV Testing For Prisoners Nationally
  • Foster Kids’ Standard Screenings Tests May Be of Low Value
  • Lessons from Ebola Can Enhance Future Diagnostic Preparedness
  • Child-Parent Cholesterol Screening Found Effective
  • Labs Must Rapidly Implement Zika Blood Supply Testing
Testing News
  • Next-Gen Sequencing, AI Driving Investor Interest in Diagnostics Sector
  • Genetic Risk Score Could Improve Diagnosis of Atrial Fibrillation
  • CDC Receives Funding to Expand Laboratory Harmonization Efforts
  • Profound Discrepancies Seen Between DTC Genetic Results, Confirmatory Testing
  • Evidence for Liquid Biopsy Lacking, Expert Panel Finds
  • Even a Single PSA Screening Test Does Not Cut Mortality
  • Cancer Mutations
  • Routine, Pre-Op Testing Costlier for Medicare Than Previously Thought
  • Venture Capital Investment in Diagnostic Companies Strong in 2017
  • LDTs, FDA-Approved Companion Diagnostics Perform Similarly; Off-Label Use of Companion Diagnostic Kits Common
  • High-Deductible Plans Tied to Reduced Use of Health Care, Including Diagnostic Testing
Genetic Testing
  • Genotyping to Guide Antiplatelet Selection Feasible, Effective
  • FDA Authorizes First Direct-to-Consumer Genetic Test for Cancer Risk
  • Racial Disparities in Access Reduce Utility of Genetic Testing
  • Genetic Tests Emerging to Advance Cardiovascular Risk Assessment
  • Genetic Testing Emerges As New Trendy Workplace Benefit
  • Gene Expression Panels Less Cost-Effective in Real-World Settings
  • New Speed Record Set for Genome Analysis
  • Malpractice Lawsuit Calls Out Lack of Genetic Counseling
  • Two App Marketplaces Ramping Up Consumer Genomics Offerings
  • Genetic Risk Score Could Improve Diagnosis of Atrial Fibrillation
  • Labs Can Provide Novel Support for Physicians Ordering Multigene Panels
  • Genomic Testing May Be Currently Overhyped, Oncologists Say
  • Phone-Based Genetic Counseling Supports Healthy Genome Sequencing
Testing Regs & Guidelines
  • Federal Guidelines for Workplace Drug Testing Add Opioids
  • Joint Guideline Issued for CRC Molecular Testing
  • Testing Guidelines at a Glance
  • New Guidance on the Use of Lab Testing to Monitor Pain Management Patients
  • FDA Warns About Biotin Interference With Lab Tests
  • Pediatric Offices Fail to Act on 1 in 10 Abnormal Test Results
  • AMP Issues Consensus Guidelines for NGS Bioinformatics Pipelines
  • FDA Considering Self-Collection Sample Regulation
AND MUCH MORE !
Join Now
Diagnostic Testing & Emerging Technologies 888-729-2315